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Rheumatoid arthritis (RA) is a systemic autoimmune inﬂammatory disease, with a pro-
gressive course, characterized by chronic synovitis that may evolve with deformities and
functional disability, and whose early treatment minimizes joint damage. Its etiopathogen-
esis is not fully elucidated but comprises immunologic responses mediated by T helper cells
(Th1). An apparent minor severity of RA in patients from regions with lower income could be
associated with a higher prevalence of gut parasites, especially helminths. Strictly, a shift in
the  immune response toward the predominance of T helper cells (Th2), due to the chronic
exposure to helminths, could modulate negatively the inﬂammation in RA patients, result-
ing  in lower severity/joint injury. The interaction between the immunological responses of
parasitic helminths in rheumatoid arthritis patients is the purpose of this paper.
©  2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Parasitoses  intestinais:  efeito  protetor  na  artrite  reumatoide?
r  e  s  u  m  oalavras-chave: A artrite reumatoide (AR) é uma doenc¸a inﬂamatória autoimune, sistêmica, de curso pro-
da por exuberante sinovite crônica, que pode gerar deformidades ertrite reumatoide gressivo, caracterizaPlease cite this article in press as: Oliveira SM, et al. Intestinal parasites infection: protective effect in rheumatoid arthritis? Rev Bras Reumatol.
2016. http://dx.doi.org/10.1016/j.rbre.2016.06.004
arasitoses intestinais
munomodulac¸ão
incapacidade funcional, cujo tratamento precoce minimiza o dano às juntas. Sua etiopato-
genia ainda não está completamente elucidada, mas compreende respostas imunológicas
com  a participac¸ão de células T auxiliares (Th1). Uma aparente menor gravidade da AR
 Study conducted at the Rheumatology Department, Hospital Universitário de Brasília (HUB), Brasília, DF, Brazil.
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ttp://dx.doi.org/10.1016/j.rbre.2016.06.004
255-5021/© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/4.0/).
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em pacientes de regiões com menor renda poderia estar associada a maior prevalência
de  parasitoses intestinais, especialmente as helmintíases. A rigor, um desvio na resposta
imune  para o predomínio de células T auxiliares (Th2), decorrente da exposic¸ão crônica a
helmintos, modularia negativamente a inﬂamac¸ão em doentes com AR, e levaria a menor
gravidade e dano articular. A revisão de aspectos da inﬂuência da reposta imunológica nas
parasitoses intestinais, especialmente as helmintíases, em pacientes com artrite reuma-
toide é o objetivo desse trabalho.
© 2016 Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC
synovitis, besides promoting a direct activation of osteoclasts,Introduction
Rheumatoid arthritis (RA) is a chronic, progressive, systemic
inﬂammatory autoimmune disease characterized by a sym-
metrical involvement of the synovial membrane of peripheral
joints with joint damage and destruction.1 Its prevalence
is estimated at 0.2–1% of the population,2 predominantly
in women and with its highest incidence in the age group
of 30–50 years.1 RA is a multifactorial disease of unknown
etiology, for which genetic (HLA-DR1 and HLA-DR4) and
environmental (exposure to infections and smoking, among
others) factors contribute for the loss of tolerance and organ
damage.3 If not treated properly, the disease can lead to func-
tional limitations, with irreversible deformities and a reduced
life expectancy.1 The impact of RA is signiﬁcant for both the
patient (morbidity and mortality and decreased quality of life)
and society (functional impairment with decreased productiv-
ity and lower capacity to participate in the labor market).2
Intestinal parasites infections include infections caused by
protozoa and helminths with high morbidity and mortality.
Their prevalence is estimated at 30% of the population of the
Americas.4,5
Despite the morbidity and, less commonly, mortality that
may be associated with parasitic infections, speciﬁcally in
the case of helminths, subclinical infestations occur, which
denounces an adaptation of the host to the parasite, with con-
tainment of damage and consequent survival of both sides.
This host/parasite adaptation is related to components of the
innate immune response and, in the case of the adaptive
immune response, to the predominance of a Th2 response,
with increased release of the so-called anti-inﬂammatory
cytokines, such as interleukins (IL) 4, 10 and 13.5
In the literature, there are reports of lower prevalence
and/or severity of RA in populations of sub-Saharan Africa;
in our midst, a study conducted in Natal/RN, while addressing
patients with systemic lupus erythematosus, found a simi-
lar level of severity in lupus patients versus populations of
areas of greater economic power.6 More  recently, in a study
on children with juvenile idiopathic arthritis cared for at
a tertiary center in the state of Ceará, their authors found
that about two-thirds of patients could achieve remission
using methotrexate and/or leﬂunomide, despite the preva-
lence of the polyarticular subtype, which would have a worse
prognosis.7 The delays in establishing the diagnosis and inPlease cite this article in press as: Oliveira SM, et al. Intestinal parasites in
2016. http://dx.doi.org/10.1016/j.rbre.2016.06.004
offering an early treatment, as well as the low family educa-
tion/income found in our population, are factors considered as
capable to aggravate the prognosis in autoimmune diseases. ItBY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
is curious, therefore, that the long-term progression of these
patients is at least equivalent, if not less severe, than that
observed in populations with better socioeconomic indicators.
This good response in potentially more  severe patients, when
compared to case series from rich countries of the Northern
hemisphere, opens the possibility that environmental factors
may be acting in the clinical course of autoimmune diseases.
The aim of this study is to elucidate the potential pro-
tective effect that the concomitant infection with intestinal
parasites, especially helminths, could provide to patients with
RA. In the period from May to July 2015, a literature review
was carried out through Pubmed (1970–2015) and Scopus
databases (English and Portuguese idioms), with the use of
the following keywords: ‘rheumatoid arthritis,’ ‘helminths,’
‘immunopathogeny’ and ‘hygiene hypothesis’.
Immunopathogenesis  of  rheumatoid  arthritis
The synovium or synovial membrane is considered as that tis-
sue where the inﬂammatory process begins and perpetuates
in RA, with the occurrence of a predominantly mononuclear
inﬂammatory inﬁltrate, synovial hyperplasia and vascular
proliferation associated with the production of proinﬂam-
matory cytokines. This hyperplastic synovium constitutes
the synovial pannus that, through the invasion of the sub-
chondral bone and underlying cartilage and also of tendons
and ligaments, leads to joint destruction.3,8 The basic mech-
anism proposed is the loss of immunological tolerance to
self-antigens in a genetically susceptible individual, triggering
synovitis.3 In relation to mechanisms of the innate immune
response, neutrophils, macrophages, mast cells and natu-
ral killer cells participate in this inﬂammatory response in
the synovium.3 Macrophages participate both in the role of
antigen-presenting cells, as effector cells, through the release
of the so-called pro-inﬂammatory cytokines (e.g. tumor necro-
sis factor (TNF)- and IL-1, IL-6, IL-12, IL-15, IL-18 and IL-23),
reactive oxygen species, and production of prostanoids and
extracellular matrix metalloproteinases.3 It is assumed that
TNF- plays a central role in the pathogenesis of RA, promot-
ing the release of other inﬂammatory mediators (i.e., cytokines
with autocrine and paracrine action) and that the activation
of lymphocytes and macrophages contribute to exacerbate thefection: protective effect in rheumatoid arthritis? Rev Bras Reumatol.
which induce bone resorption.3
Classically, RA is described as an autoimmune disease
mediated by T cells, especially effector Th1 and Th17 cells.5,8
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he differentiation of monocytes into osteoclasts is indirectly
romoted by TNF through the activation of the receptor acti-
ator of nuclear factor kappa-B ligand (RANKL), a member
f the superfamily of TNF.9 This action of TNF turns out to
mplicate this factor in the inﬂammatory bone resorption
n cases of RA, since the result of RANKL activation stimu-
ates the differentiation and activation of osteoclasts, besides
nhibiting the apoptosis of these cells.10 Furthermore, IL-17
roduction by Th17 lymphocytes, present in high levels in
he synovia of patients with RA, regulates the expression of
ANKL, contributing to osteoclastogenesis and progression of
oint damage.9 Although the frequency of regulatory T cells
D4+ and CD25+, responsible for inhibiting the proliferation
nd production of cytokines by effector T cells, is increased
n the synovial ﬂuid of RA patients, it is unclear whether
hese cells are activated in this environment, taking into
ccount that there is a loss of self-tolerance to self-antigens,
hich contributes to the persistence of the joint inﬂammatory
rocess.9 Moreover, T cell apoptosis is inhibited, probably due
o the high level of anti-apoptotic cytokines such as IL-2, IL-4,
nd IL-15, present earlier in RA.9
There is also a contribution of humoral immune response
n RA, through the differentiation and proliferation of B cells
hat produce cytokines and can function as class II anti-
en presenting cells, contributing to the perpetuation of
ynovitis.9 The presence of autoantibodies against the Fc
ortion of IgG molecules, such as the rheumatoid factor, which
llustrates the humoral component in RA, is detectable in
0–80% of patients, but such molecules can also be found
n healthy individuals and in patients with other systemic
iseases.9 Antibodies against the citrullination of arginine to
itrulline as a result of deamination (anti-cyclic citrullinated
eptides) may be present in up to 70% of patients, and these
olecules appear early in patients with RA.9 The exact role of
hese autoantibodies in the pathogenesis of RA has still not
een cleared up, but it is known that seropositive patients in
igh titers to these antigens tend to exhibit a more  aggressive
isease, with greater joint damage and bone erosion, as well
s with extra-articular manifestations.3,5
mmunopathogenesis  of  intestinal  parasites
nfection
arasites such as helminths may modulate the immune
esponse, inducing an anti-inﬂammatory environment that
avors their survival within the host, that is, these para-
ites suppress proinﬂammatory immune responses in order
o maintain their life cycle.3,11 Intestinal parasitic infections
re chronic phenomena, and re-infestation is often seen;
nd such organisms, in addition to the inhibitory changes
hat they cause in innate and adaptive immune responses,
lso have mechanisms to escape the host immune response
y reducing their immunogenicity.5 In general, helminths
urvive within the host and cause persistent infections, appar-
ntly because of a decrease in the innate immune response
5,12Please cite this article in press as: Oliveira SM, et al. Intestinal parasites in
2016. http://dx.doi.org/10.1016/j.rbre.2016.06.004
gainst the parasites. The combined action of mast cells
nd eosinophils contributes to the containment of intestinal
arasites.5 Such parasites are resistant to phagocytosis and
o cytocidal mechanisms of macrophages and neutrophils.5 6;x  x x(x x):xxx–xxx 3
Moreover, some helminths may also activate the alternative
pathway of the complement system and are resistant to the
lysis mediated by proteins pertaining to that system.5
In helminth infections, the parasites induce the produc-
tion of IL-10 and of Th2 cytokines (IL-4, IL-5, IL-9, and IL-13),
modifying the stimulation of macrophages to an alterna-
tive activated phenotype, which favors the anti-inﬂammatory
response of Th2 cells and the eosinophilic response.3,12
Helminths also inhibit IFN-, IL-1 and IL-17, suppressing the
inﬂammatory immune response of Th1 and Th17 cells.3,12,13
The helminths secrete excretory-secretory products, such
as ES-62, which are glycosylated and act by inducing Th2
cytokines and the expansion of regulatory T cells.13 More-
over, the amount of regulatory T cells (CD4+ CD25+ FOXP3+)
that produce IL-10 and TGF- increases after infection by
helminths,3,11 thus contributing to the permanence of the par-
asite inside the host.
The homeostasis generated by these immune responses
prevents an overreaction against parasites, a thing which also
would impair the host, ensuring the survival of helminths.11,13
Protective  effect  of  helminth  infections  in
rheumatoid  arthritis
In 1970, Greenwood noted that individuals living in Nige-
rian villages, despite the high incidence of positive cases
for rheumatoid factor, had rheumatic disease of a benign
course, with a good prognosis and no radiological signs of
severity.14 Given the high prevalence of parasitic infectious
diseases in that population, it was suggested that the host
response to multiple parasites would somehow interfere in
the course of autoimmune diseases.14 The delay in the estab-
lishment of diagnosis, the difﬁculties of access to medical
expertise, the low compliance to treatment and failure or
delay in the prescription of disease-modifying drugs neg-
atively impact the prevalence and severity of autoimmune
diseases.15 Thus, patients from developing countries should
present more  signiﬁcant morbidity and mortality.15 However,
RA is less common in certain areas of tropical countries, where
a high incidence of infectious diseases, especially parasitic
ones, is observed.16 In northeastern Brazil, less severe autoim-
mune rheumatic disease was also observed, partly due to
possibly endemic parasitic infestations.17 In 1989, Strachan
proposed his “hygiene hypothesis” theory: the reduction of
exposure to common pathogens, such as helminths, increased
the prevalence of allergic and autoimmune diseases in areas
where sanitary conditions improved.3,6,12,13,18–21
Intestinal parasites are suppressors of proinﬂammatory
immune response, so these organisms can live in equilib-
rium with the host immune system.3,12 Thus, in addition to
causing disease, they also act as potent modulators of the
immune system.3 The parasites related to protective effects of
the aggressiveness of the disease in patients with RA, already
described in the literature, are Schistosoma mansoni, Schisto-
soma japonicum,  Ascaris suum, Heligmosomoides polygyrus bakeri
3,12,20,21fection: protective effect in rheumatoid arthritis? Rev Bras Reumatol.
and Hymenolepsis diminuta. Such pathogens inhibit the
secretion of Th1/Th17 cytokines, induce the appearance of
tolerant dendritic cells and promote the proliferation of reg-
ulatory T cells.21 The infection by Schistosoma mansoni or
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by S. japonicum can modify the function of dendritic cells,
macrophages, NK cells and B cells, leading to an expansion
of Th2 cells and of regulatory T cells responsible for maintain-
ing self-tolerance.11,18 The infection of mice with Schistosoma
japonicum prior to the induction of arthritis by collagen (inter-
val of 2 weeks) signiﬁcantly attenuated the clinical signs of
arthritis, with decreases in synovial hyperplasia, inﬁltration of
synovial mononuclear cells, angiogenesis in inﬂamed synovia,
osteoclast activation, and joint destruction.11 A lower produc-
tion of IFN- and an increase in IL-4 and IL-10 were observed,
together with decreases in proinﬂammatory cytokine (TNF-
, IL-1 , IL-6 and IL-17, IFN-, RANKL) levels; these ﬁndings
suggest a predominance of Th2 response and a reduction of
Th1 response.11,18 This change in the immunological proﬁle
explains the lower aggressiveness and even the absence of
joint disease in the studied models.11,18 However, the infection
of mice with Schistosoma japonicum after the collagen-induced
arthritis could not reverse the immune response already
installed, nor the subsequent joint damage.11
Studies using Ascaris suum extract (a non-pathogenic prod-
uct to humans) administered both orally and parenterally in
a murine model of arthritis induced by zymosan and colla-
gen demonstrated anti-inﬂammatory effects of the extract, in
order to reduce hyperalgesia and the damage to the articular
cartilage.15,17 The mechanism associated with the response to
this helminth extract was a diminished release of inﬂamma-
tory mediators – nitric oxide, IL-10, and IL-1 – to the mice’s
joints.17 There was no change in TNF- levels.17
In an individual with an autoimmune rheumatic disease
such as RA, the helminth infection has the potential to allevi-
ate the symptoms and improve the progressive course of the
disease, thanks to the induction of an immune response by
Th2 cells, antagonistic to the response by Th1 cells present
in autoimmune disease.6,19 In addition to inhibiting Th1
cytokines, the induction of regulatory cytokines (IL-10 and
TGF-), the production of regulatory T cells FOXP3 and the
activity of alternatively activated macrophages also would
inﬂuence in the protective effect of helminth infections in
patients with RA.20
Given the hypothesis that individuals infected with
helminths would be less susceptible to other inﬂammatory
diseases, the parasitic infection could inﬂuence the treatment
of diseases mediated by Th1 cells.20
The helminth infections and the products derived from
helminths (such as ES-62) are valuable tools to the under-
standing of the immune responses caused by these parasites,
possibly helping in identifying new clinically relevant ther-
apeutic targets.13 Immunomodulatory products – puriﬁed or
synthesized – obtained from helminths must be studied, in
order to be used clinically.15,19 The challenge is to identify and
characterize speciﬁc antigens of a given helminth that tar-
get the protective response, and also antigens/molecules that
would serve as indicators in the development of new biophar-
maceutical agents for treating a number of diseases, among
them RA.20Please cite this article in press as: Oliveira SM, et al. Intestinal parasites in
2016. http://dx.doi.org/10.1016/j.rbre.2016.06.004
Conclusion
RA is a debilitating and painful systemic illness, whose
immunopathogenesis involves innate and adaptive immune
1 1 6;x  x x(x x):xxx–xxx
mechanisms, especially with Th1 cell activity and release of
inﬂammatory cytokines, for example, TNF-. An early treat-
ment can modify the aggressive and disabling course of this
disease. Today, we  can rely on effective biological therapies
for the treatment of RA, targeted to blocking speciﬁc inﬂam-
matory cytokines. It is assumed that the generation of an
immunologically balanced environment, as a result of the
infection by helminths, could reduce the severity of a concur-
rent autoimmune rheumatic disease. A better understanding
of the modulation pathways of the anti-inﬂammatory action
provided by the infection with helminths, or by their secre-
tory products, may lead to new therapeutic strategies (capable
of inhibiting more  broadly the inﬂammatory cytokines) and
amplify the therapeutic arsenal currently available for RA.
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